This study will gather valuable data for an underrepresented group of patients diagnosed with cancer carrying an extremely high mortality rate.

Pancreatic cancer represents 3.1% of all new cancer cases in the U.S., with only 7.7% of people surviving 5 years or more after their diagnosis. Several genetic syndromes caused by inherited gene mutations may pose a risk for pancreatic cancer, leaving an underlying genetic mechanism to be the cause in ~10% of all pancreatic cancer. High risk gene mutations, such as those in the BRCA2 gene, are identified in families presenting with a constellation of tumors (including breast, ovarian, pancreatic cancer) but may go undetected in families with only a clustering of pancreatic tumors or isolated pancreatic cancer cases. Read more . . .